Weight loss · Philadelphia area, PA
Weight loss and obesity studies in Philadelphia area, PA
13 recruiting studies have a site in the Philadelphia area. This page includes nearby cities such as Upland, Bryn Mawr, Wynnewood, Abington.
13 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Philadelphia, PA + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 3
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Eli Lilly and Company
- Location
- Plymouth Meeting, PA + 37 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Eli Lilly and Company
- Location
- Media, PA + 68 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Eli Lilly and Company
- Location
- Philadelphia, PA + 36 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Eli Lilly and Company
- Location
- Philadelphia, PA + 34 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Novo Nordisk A/S
- Location
- Philadelphia, PA + 21 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice…
Eli Lilly and Company
- Location
- Plymouth Meeting, PA + 38 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
Rhythm Pharmaceuticals, Inc.
- Location
- Philadelphia, PA + 7 other US sites
- Eligibility basics
- Ages 4+
- RecruitingHealthy volunteers
Medical Residents Learning Weight Management Counseling Skills
University of Massachusetts, Worcester
- Location
- Hershey, PA + 6 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
An Acceptance-Based Healthy Lifestyle Intervention for Diverse Adolescents
Nemours Children's Clinic
- Location
- Philadelphia, PA
- Eligibility basics
- Ages 14–19 · Women only
- RecruitingHealthy volunteers
Optimizing a Mobile Health Platform for Sleep Promotion and Obesity Prevention in Children
Children's Hospital of Philadelphia
- Location
- Philadelphia, PA
- Eligibility basics
- Ages 8–12
- RecruitingHealthy volunteers
RemI for Post-Bariatric Surgery Weight Regain
Temple University
- Location
- Philadelphia, PA + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteers
Nurturing Needs Study: Parenting Food Motivated Children
Temple University
- Location
- Philadelphia, PA + 1 other US site
- Eligibility basics
- Ages 4–5
Who these studies look for
Most of these studies set a BMI range and may exclude people taking certain weight-loss medicines or who have had bariatric surgery. Some require a weight-related condition such as type 2 diabetes or high blood pressure.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.